Sotera Health Company (SHC)
Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q2 2025 Earnings Conference Call August 8, 2025 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Jonathan M. Lyons - Senior VP & CFO Michael B.
Exploring Analyst Estimates for Sotera Health (SHC) Q2 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Sotera Health (SHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Officer Jason Peterson - Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly - Citi Brett Fishbin - KeyBanc Matt Sykes - Goldman Sachs Luke Sergott - Barclays Dave Windley - Jefferies Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call.
Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago.
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?
Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately.
Sotera Health Has A Great Deleveraging Path Ahead
Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging.
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call.
Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sotera Health Company (SHC) Meets Q4 Earnings Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.26 per share a year ago.
Insights Into Sotera Health (SHC) Q4: Wall Street Projections for Key Metrics
Evaluate the expected performance of Sotera Health (SHC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Sean Dodge - RBC Capital Markets Patrick Donnelly - Citigroup Inc. Salem Salem - Barclays Brett Fishbin - KeyBanc Capital Markets Casey Woodring - J.P. Morgan Chase Jason Bednar - Piper Sandler Dave Windley - Jefferies Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Third Quarter 2024 Conference Call.
